Clinical Trial Update: A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis [NA]

View source ↗

Summary

Clinical trial update describing a study of peginterferon alfa-2b combined with nucleos(t)ide analogs in compensated HBV-related liver cirrhosis, currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbv-related Liver Cirrhosis

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: Xiamen Humanity Hospital | Conditions: HBV-related Liver Cirrhosis | NA | Status: NOT_YET_RECRUITING